glp 1 multiple sclerosis The Multifaceted Nature of GLP-1: Molecular Mechanisms and Signaling Pathways in Metabolic and Neurodegenerative Diseases Are GLP-1 Drugs Safe For

A recent example is the SELECT trial finding that Ozempic (semaglutide) reduced cardiovascular events by 20% in overweight or obese adults with established heart disease and without diabetes

[4] [6] This relationship is bidirectional and complex, involving: Inflammatory pathways that affect both metabolic and mental health Hormonal dysregulation impacting mood and stress responses Psychosocial factors including stigma, body image concerns, and chronic disease burden Lifestyle factors such as reduced physical activity and poor sleep quality When GLP-1 medications improve glycaemic control, facilitate weight loss, and enhance overall metabolic health, patients may experience secondary improvements in psychological wellbeing

Photo by Innerbody Research Increasingly more people are turning to therapeutic peptides to shed weight

F., Kuo, C

K., & Seydim, A